Payment for whole blood donations in Lithuania: the risk for infectious disease markers

Kalibatas, Vytenis

doi:10.1111/j.1423-0410.2007.01015.x

Cited by 31 publications

(27 citation statements)

References 6 publications

(8 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In keeping with these findings, a more recent study from Lithuania assessing both regular and first-time whole blood donors found that blood from first-time paid donors was of poorer quality (Kalibatas, 2008). …”

mentioning

confidence: 69%

Incentivizing blood donation: Systematic review and meta-analysis to test Titmuss’ hypotheses.

Niza¹,

Tung²,

Marteau³

2013

Health Psychology

View full text Add to dashboard Cite

Objectives: Titmuss hypothesized that paying blood donors would reduce the quality of the blood donated and would be economically inefficient. We report here the first systematic review to test these hypotheses, reporting on both financial and nonfinancial incentives. Method: Studies deemed eligible for inclusion were peer-reviewed, experimental studies that presented data on the quantity (as a proxy for efficiency) and quality of blood donated in at least two groups: those donating blood when offered an incentive, and those donating blood with no offer of an incentive. The following were searched: MEDLINE, EMBASE and PsycINFO using OVID SP, CINAHL via EBSCO and CENTRAL, the Cochrane Library, Econlit via EBSCO, JSTOR Health and General Science Collection, and Google. Results: The initial search yielded 1100 abstracts, which resulted in 89 full papers being assessed for eligibility, of which seven studies, reported in six papers, met the inclusion criteria. The included studies involved 93,328 participants. Incentives had no impact on the likelihood of donation (OR = 1.22 CI 95% 0.91–1.63; p = .19). There was no difference between financial and nonfinancial incentives in the quantity of blood donated. Of the two studies that assessed quality of blood, one found no effect and the other found an adverse effect from the offer of a free cholesterol test (β = 0.011 p < .05). Conclusion: The limited evidence suggests that Titmuss’ hypothesis of the economic inefficiency of incentives is correct. There is insufficient evidence to assess their likely impact on the quality of the blood provided.

show abstract

mentioning

confidence: 69%

Incentivizing blood donation: Systematic review and meta-analysis to test Titmuss’ hypotheses.

Niza¹,

Tung²,

Marteau³

2013

Health Psychology

View full text Add to dashboard Cite

show abstract

“…Safety of donor’s blood is still a worldwide health care problem which could be partially solved by introducing more sensitive NAT methods. However, it will not be solved completely, especially in the case of paid donations [31,32,43]. …”

Section: Discussionmentioning

confidence: 99%

Anti-HCV prevalence in the general population of Lithuania

Liakina

Valantinas

2012

Med Sci Monit

View full text Add to dashboard Cite

SummaryBackgroundThe aim of this study was to assess risk factors for HCV acquisition and prevalence of anti-HCV in the general population of Lithuania.Material/MethodsThe study enrolled 1528 randomly selected adults from the 5 biggest cities of Lithuania and its rural regions. Screening for anti-HCV was performed by analysis of peripheral capillary blood with lateral flow immunochromatography and confirmation of positive cases by peripheral venous blood testing with 2-step chemiluminescent microparticle immunoassay.ResultsAnti-HCV prevalence in Lithuania is 2.78% and according to the standard European population the adjusted anti-HCV rate is 2.85%. It is more prevalent among men (crude rates: 4.02% males vs. 1.49% females, p=.0030) and this does not depend on age. Vilnius and Kaunas regions have higher infection rates than smaller rural regions (2.92% and 3.01% vs. 2.24%, 0.74% and 1.35%). Nowadays among our population HCV infection spreads mainly via intravenous drug use (OR=42.5, p<.0001). HCV transmission occurs through blood transfusions (OR=6.4, p=.0002), tooth removal (OR=4.1, p=.0048), childbirth (OR=5.0, p=.0224), multiple and a long-term hospitalization (OR=3.0, p=.0064), tattooing (OR=4.4, p=.0013), open traumas (OR=3.7, p=.0009) and intrafamilially (OR=11.3, p=.0002).Conclusions2.78% of the population is anti-HCV-positive. The anti-HCV rate is higher in Vilnius and Kaunas in comparison with other regions. HCV spreads mainly through intravenous drug use, but intrafamilial and some nosocomial routes are also important. The anti-HCV prevalence did not depend on age. Despite active prevention of nosocomial HCV transmission, the incidence of HCV infection does not decrease due to virus spread mostly in “trusted networks” of intravenous drug users.

show abstract

“…Reports in most countries in Sub-Saharan Africa have indicated a high prevalence of TTIs among commercially remunerated blood donors 27,28. Commercially remunerated donors often come from the poorest sectors of the economy, may be poor in health, are more likely to give blood more often than recommended, and are also at a higher risk of being undernourished and having a TTI from high-risk behaviors such as maintenance of multiple sex partners, intravenous drug abuse, and unprotected sexual intercourse 29–32…”

Section: Challenges Of Recruitment Of Voluntary Nonremunerated Donorsmentioning

confidence: 99%

The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood

Erhabor

Charles²

2011

JBM

View full text Add to dashboard Cite

As a resource, allogenic blood has never been more in demand than it is today. Escalating elective surgery, shortages arising from a fall in supply, a lack of national blood transfusion services, policies, appropriate infrastructure, trained personnel, and financial resources to support the running of a voluntary nonremunerated donor transfusion service, and old and emerging threats of transfusion-transmitted infection, have all conspired to ensure that allogenic blood remains very much a vital but limited asset to healthcare delivery particularly in Sub-Saharan Africa. This is further aggravated by the predominance of family replacement and commercially remunerated blood donors, rather than regular benevolent, nonremunerated donors who give blood out of altruism. The demand for blood transfusion is high in Sub-Saharan Africa because of the high prevalence of anemia especially due to malaria and pregnancy-related complications. All stakeholders in blood transfusion have a significant challenge to apply the best available evidenced-based medical practices to the world-class management of this precious product in a bid to using blood more appropriately. Physicians in Sub-Saharan Africa must always keep in mind that the first and foremost strategy to avoid transfusion of allogenic blood is their thorough understanding of the pathophysiologic mechanisms involved in anemia and coagulopathy, and their thoughtful adherence to the evidenced-based good practices used in the developed world in a bid to potentially reduce the likelihood of allogenic blood transfusion in many patient groups. There is an urgent need to develop innovative ways to recruit and retain voluntary low-risk blood donors. Concerns about adverse effects of allogenic blood transfusion should prompt a review of transfusion practices and justify the need to search for transfusion alternatives to decrease or avoid the use of allogenic blood. These strategies should include the correction of anemia using pharmacological measures (use of antifibrinolytics to prevent bleeding and the use of erythropoietin and oral and intravenous iron to treat anemia) use of nonpharmacologic measures (preoperative autologous blood transfusion, perioperative red blood cell salvage and normothermia to reduce blood loss in surgical patients). All these strategies will help optimize the use of the limited blood stocks.

show abstract

Payment for whole blood donations in Lithuania: the risk for infectious disease markers

Abstract: The payment for whole blood donors provides a higher risk for infectious disease markers of first-time donations at the National Blood Center in Lithuania.

Cited by 31 publications

References 6 publications

Incentivizing blood donation: Systematic review and meta-analysis to test Titmuss’ hypotheses.

Incentivizing blood donation: Systematic review and meta-analysis to test Titmuss’ hypotheses.

Anti-HCV prevalence in the general population of Lithuania

The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood

Contact Info

Product

Resources

About